Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James D Otvos

Showing results (11-20 of 145) with videos related to

Pageof 15
Sort By:
Metabolic Syndrome and Related Disorders|June 25, 2014
Lipoprotein insulin resistance index: a lipoprotein particle-derived measure of insulin resistanceIrina Shalaurova, Margery A Connelly, W Timothy Garvey, et al.
Circulation|October 9, 2002
Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in womenGavin J Blake, James D Otvos, Nader Rifai, et al.
Atherosclerosis|January 5, 2002
Effects of pravastatin treatment on lipoprotein subclass profiles and particle size in the PLAC-I trialJames D Otvos, Irina Shalaurova, David S Freedman, et al.
Metabolism: Clinical and Experimental|February 4, 2005
Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis StudyDavid C Goff, Ralph B D'Agostino, Steven M Haffner, et al.
The Journal of Pediatrics|August 31, 2010
The triglyceride to high-density lipoprotein-cholesterol ratio in adolescence and subsequent weight gain predict nuclear magnetic resonance-measured lipoprotein subclasses in adulthoodRam Weiss, James D Otvos, Ronit Sinnreich, et al.
JACC. Case Reports|October 27, 2022
Lipoprotein-X and Lipoprotein-Z Induced Hyperviscosity Syndrome in the Setting of Cholestatic Liver FailureOri Waksman, Daniel J Cho, HyoungSup Kim, et al.
Clinical Chemistry|June 25, 2011
Lipoprotein subclass abnormalities and incident hypertension in initially healthy womenNina P Paynter, Howard D Sesso, David Conen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 18, 2016
Inflammatory glycoproteins in cardiometabolic disorders, autoimmune diseases and cancerMargery A Connelly, Eke G Gruppen, James D Otvos, et al.
Practical Laboratory Medicine|April 19, 2021
High-throughput nuclear magnetic resonance measurement of citrate in serum and plasma in the clinical laboratoryErwin Garcia, Margery A Connelly, Steven P Matyus, et al.
Journal of Translational Medicine|October 29, 2017
GlycA, a novel biomarker of systemic inflammation and cardiovascular disease riskMargery A Connelly, James D Otvos, Irina Shalaurova, et al.
Pageof 15

Showing results (11-20 of 145) with videos related to

Sort By:
Pageof 15
Metabolic Syndrome and Related Disorders|June 25, 2014
Lipoprotein insulin resistance index: a lipoprotein particle-derived measure of insulin resistanceIrina Shalaurova, Margery A Connelly, W Timothy Garvey, et al.
Circulation|October 9, 2002
Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in womenGavin J Blake, James D Otvos, Nader Rifai, et al.
Atherosclerosis|January 5, 2002
Effects of pravastatin treatment on lipoprotein subclass profiles and particle size in the PLAC-I trialJames D Otvos, Irina Shalaurova, David S Freedman, et al.
Metabolism: Clinical and Experimental|February 4, 2005
Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis StudyDavid C Goff, Ralph B D'Agostino, Steven M Haffner, et al.
The Journal of Pediatrics|August 31, 2010
The triglyceride to high-density lipoprotein-cholesterol ratio in adolescence and subsequent weight gain predict nuclear magnetic resonance-measured lipoprotein subclasses in adulthoodRam Weiss, James D Otvos, Ronit Sinnreich, et al.
JACC. Case Reports|October 27, 2022
Lipoprotein-X and Lipoprotein-Z Induced Hyperviscosity Syndrome in the Setting of Cholestatic Liver FailureOri Waksman, Daniel J Cho, HyoungSup Kim, et al.
Clinical Chemistry|June 25, 2011
Lipoprotein subclass abnormalities and incident hypertension in initially healthy womenNina P Paynter, Howard D Sesso, David Conen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 18, 2016
Inflammatory glycoproteins in cardiometabolic disorders, autoimmune diseases and cancerMargery A Connelly, Eke G Gruppen, James D Otvos, et al.
Practical Laboratory Medicine|April 19, 2021
High-throughput nuclear magnetic resonance measurement of citrate in serum and plasma in the clinical laboratoryErwin Garcia, Margery A Connelly, Steven P Matyus, et al.
Journal of Translational Medicine|October 29, 2017
GlycA, a novel biomarker of systemic inflammation and cardiovascular disease riskMargery A Connelly, James D Otvos, Irina Shalaurova, et al.
Pageof 15